514103 rrid ab 3720459 (Santa Cruz Biotechnology)
Structured Review
514103 Rrid Ab 3720459, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 28 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brd2/BRD2+Antibody/pmc12828559-7-5-2
Average 92 stars, based on 28 article reviews
Images
Related Articles
other:Article Title: BRD3 PROTAC degrader targets H3K18ac to alleviate retinal microglia-driven uveitis Article Snippet: Western Blot:Article Title: Resistance of estrogen receptor function to BET bromodomain inhibition is mediated by transcriptional coactivator cooperativity. Article Snippet: The bromodomain and extraterminal domain (BET) family of proteins are critical chromatin readers that bind to acetylated histones through their bromodomains to activate transcription.. Here, we reveal that bromodomain inhibition fails to repress oncogenic targets of estrogen receptor because of an intrinsic transcriptional mechanism.. While bromodomains are necessary for the transcription of many genes, bromodomain-containing protein 4 (BRD4) binds to estrogen receptor binding sites and activates transcription of critical oncogenes such as MYC, independently of its bromodomains. Chromatin Immunoprecipitation:Article Title: Resistance of estrogen receptor function to BET bromodomain inhibition is mediated by transcriptional coactivator cooperativity. Article Snippet: The bromodomain and extraterminal domain (BET) family of proteins are critical chromatin readers that bind to acetylated histones through their bromodomains to activate transcription.. Here, we reveal that bromodomain inhibition fails to repress oncogenic targets of estrogen receptor because of an intrinsic transcriptional mechanism.. While bromodomains are necessary for the transcription of many genes, bromodomain-containing protein 4 (BRD4) binds to estrogen receptor binding sites and activates transcription of critical oncogenes such as MYC, independently of its bromodomains. Blocking Assay:Article Title: Inhibition of Brd4 alleviates osteoarthritis pain via suppression of neuroinflammation and activation of Nrf2-mediated antioxidant signalling. Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Numbers: 82001198, 82071556, 82101310, 82271291; National Key Research and Development Program of China, Grant/Award Number: 2020YFC2005303 Abstract Background and Purpose: Osteoarthritis (OA) pain remains a major clinical problem.. It is urgent to identify novel therapeutic approaches for OA pain states.. Bromodomain and extra-terminal (BET) protein inhibitors have robust anti-inflammatory effects in several pain models. Incubation:Article Title: Inhibition of Brd4 alleviates osteoarthritis pain via suppression of neuroinflammation and activation of Nrf2-mediated antioxidant signalling. Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Numbers: 82001198, 82071556, 82101310, 82271291; National Key Research and Development Program of China, Grant/Award Number: 2020YFC2005303 Abstract Background and Purpose: Osteoarthritis (OA) pain remains a major clinical problem.. It is urgent to identify novel therapeutic approaches for OA pain states.. Bromodomain and extra-terminal (BET) protein inhibitors have robust anti-inflammatory effects in several pain models. Article Title: Differential responses of pulmonary vascular cells from PAH patients and controls to TNFα and the effect of the BET inhibitor JQ1. Article Snippet: .. After washing in PBS, sections were incubated for 1 h with |

